Background: Poor nebuliser hygiene can result in bacterial contamination and
Multiple drug regimens are often required to attain optimal outcome. This dependence on time consuming regimens increases treatment burden and often impacts on adherence. The introduction of devices such as the e Flow® and iNeb® have helped to reduce some of this burden by improved portability, usability and speed of administration (1) . Despite these changes adherence to treatment and nebuliser hygiene can remain low (2, 3) .
Previous studies have demonstrated a relationship between nebuliser hygiene and the risk of bacterial infections (4) (5) (6) (7) . Despite the high prevalence of fungal 3 colonisation and infection in patients with CF, the role of nebuliser devices as a potential source of primary inoculum and re-infection has not been investigated. Aspergillus fumigatus remains the most common fungal species to affect patients with CF and can be isolated in up to 58% of sputum samples. The fungus results in a spectrum of conditions ranging from hypersensitivity to frank infection (8) . These include bronchopulmonary aspergillosis (ABPA), aspergillus bronchitis, aspergilloma and in post transplant recipents, invasive aspergillosis. Other fungi such as Scedosporium apiospermum have also been implicated in pulmonary exacerbation.
The aim of this study was to analyse the fungal flora of nebuliser devices from people with CF and to compare contamination rates between the various devices.
Materials and Methods

Subjects
Adult attending the Leeds CF Unit at St James University Hospital were prospectively recruited. All patients had classical features of cystic fibrosis in conjunction with either two mutations or two abnormal sweat tests. Following recruitment, subjects were requested to bring their nebuliser devices to their next outpatient appointment. No further information was provided and cleaning was not mentioned. The study was approved by the North Leeds Ethics Committee (11/YH/0296).
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Device sampling Samples were obtained from the equipment by wetting a sterile cotton swab with sterile water and swabbing each drug chamber. INeb horns were swabbed separately. Some individuals with INebs had multiple chambers.
Samples as well as negative controls were sent to the Mycology Laboratory at Leeds General Infirmary.
Laboratory investigations
Swabs were plated out on Sabouraud agar and on Scel+ agar to select for Scedosporium sp (9) . All plates were incubated at 27 o C for up to two weeks.
Any mould or yeast growing on the plate was identified immediately or stored at -80 o C prior to being recovered and identified at a later date. Yeasts were initially identified by germ tube test. All germ tube negative isolates were identified by MALDI-TOF examination using the Bruker Biotyper system(10) or where this was not successful, the Biomerieux API32C yeast identification method. Moulds were identified by microscopic examination, or if this was not sufficient, by sequencing of the ITS1, 5.8S and ITS2 region and comparing the sequence with the Genbank database by BLAST search (11) . Sputa were treated with an equal volume of 0.1% dithiothreitol and a 10ul loopful inoculated onto 3 Sabourauds agar plates which were incubated for 7 days at 28, 35 and 45C. All moulds are routinely examined though not always identified to species level.
Analysis 5
The proportion of devices with any fungal contamination were analysed according to device using significance tests and assuming a normal distribution. Device cultures were compared with the previous 6 months of sputum cultures
Results
A total of 170 nebulisers, some with multiple chambers were sampled, representing a mean of 1.87 and median of 2 (range 1-4) devices from 149 subjects.
Overall, 86/149 (57.7%) of subjects had positive fungal cultures from at least one of their devices, with 39/149 (26.2%) being yeasts, 47/149 (31.5%) moulds and 20/149 (13.4%) a combination of yeasts and moulds.
There was no significant difference in the contamination rates of iNeb and Eflow devices (p >0.05) ( Table 1) . While the contamination rate of Ventstreams appeared lower, numbers of devices used were small. Similar rates of fungal contamination were seen for iNeb chambers and horns. There was no correlation between medication administered and rate of contamination ( Table 2) .
Aspergillus fumigatus was the most frequent mould isolated ( Table 3) followed by Penicillium sp. P. commune was the most common identifiable species from this genus. A number of Lecanicillium sp.isolates were also identified. Exophiala sp, were isolated from, five devices. One was identified 6 as E. oliosperma, one as E. jeanselmei and three as Exophiala sp., None were E. dermatiditis. Thus a total of 4/149 (2.7%) of all study subjects had one or more devices contaminated with Exophiala sp.
The most frequent yeast to contaminate devices was Candida guilliermondii followed by C. parapsilosis. Contamination with environmental basidiomycetous yeasts in the genera Rhodotorula and Cryptococcus (but not Cr. neoformans) was also common. The commonest cause of oral colonisation and infection, C. albicans was isolated on a single occasion.
When the results of culture from devices was compared with sputum culture from the previous six months, no obvious correlation was seen between positive culture from devices and previous sputum specimens (p >0.05). Most people with CF who were sputum culture positive for A. fumigatus (46/50) did not have devices contaminated with this fungus. Of the six study subjects with Exophiala sp. or black yeasts isolated from devices, none had Exophiala sp. isolated from sputum culture in the previous six months. Of seven study subjects who had black yeasts isolated from sputum culture in the previous 6 months (provisionally identified as Exophiala sp.), none had Exophiala isolated from devices. No Scedosporium sp. were isolated from any device.
All controls samples were negative. 
Discussion
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Although there is an increasing body of evidence supporting a relationship between nebuliser hygiene and the risk of bacterial infections (4, 5) , there is a paucity of data on fungal contamination. A recent one day study by Jadhay et demonstrated a high prevalence of fungal colonization of oxygen humidifier and Hudson's nebuliser chambers in ICUs, wards, the casualty and OPD(6).
Significantly, 15% of devices remained colonised despite disinfection with 70% alcohol.
The present study has shown a high prevalence of contaminated nebuliser devices used by patients with CF. Over 57% of subjects had positive fungal cultures in at least one device including yeasts, moulds or a combination of both. There appears to be no significant difference between the rates of contamination between the various devices. We were surprised by the similarity in the contamination rate of conventional nebulisers and those with mesh technology. We had expected to find an increase rate of contamination in the conventional devices and had not expected to isolate fungus from the horn of the ineb. While contamination of Ventstreams appeared low, numbers were too small for the results to be meaningful.
We routinely instruct patients on how to follow the manufacturer's guidelines for cleaning the various devices. It is likely that such protocols are only partially adhered to and that following initial contamination, further cleaning becomes less effective due to the presence of polymicrobial biofilms.
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There was no apparent correlation between fungal contamination of nebuliser devices and previous sputum mycology. Whilst these results do not exclude the role of the nebuliser device as a potential reservoir for pathogenic fungi much more in depth longitudinal studies are needed.
Aspergillus fumigatus was the most frequent mould isolated followed by
Penicillium sp with yeasts being found on many devices. While yeasts are regularly isolated from sputum specimens of people with CF, yeasts are not generally thought to represent a major clinical problem (12) . It was notable that the distribution of yeasts isolated from nebuliser devices did not correlate with yeasts that normally colonies or infect the oral cavity. For example Candida albicans is a common isolate from CF sputum and assumed to represent oral flora but only one device was contaminated with this species. The yeasts contaminating the nebuliser devices were often those associated with the formation of biofilms such as C. parapsilosis. Specimens also included environmental yeasts such as Rhodotorula sp, which are infrequently isolated from clinical specimens due to their inability to grow well at 37C.
In clinical practice we have recognised significant differences in patient adherence to cleaning regimens with some nebuliser and compressors being returned in a poor state of cleanliness. Education and adherence with the manufacturers cleaning regimens can reduce contamination, highlighting the importance of regular cleaning and disinfection (13) . Further research is needed to assess the relative effectiveness of different cleaning methods.
There is presently no data on the rate of fungal contamination of the new dry 9 powder antibiotic inhalers although the risk of contamination is likely to be significantly lower in these disposable devices.
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